Frontiers in Human Neuroscience · Nov 16, 2026

Cyborg Dementia: Could Structural Disembodiment Accelerate Brain Aging via Loss of Muscle-Bone Trophic Signaling? A Matter of Perspective

By Beom Su Kim, JUNG MI Oh, Sungkun Chun

Advances in brain-machine interfaces and neuroprosthetics are often framed as a path toward overcoming the biological limits of the body, with the eventual replacement of failing limbs and organs by durable artificial substitutes. Interestingly, this optimistic narrative overlooks a challenge that is becoming increasingly apparent in aging neuroscience: brain health depends critically on a continuous supply of trophic signals originating from skeletal muscle and bone. Myokines and osteokines such as irisin, uncarboxylated osteocalcin, and cathepsin B act on the brain to sustain BDNF expression, synaptic plasticity, and neurogenesis, forming what has been described as a muscle-bone-brain axis; disuse and immobilization, even in the absence of any primary brain pathology, are sufficient to disrupt this signaling and accelerate cognitive decline. This raises a largely unaddressed question for cyborg technologies: could a robotic body, mechanically capable of movement but biologically inert and secreting none of the trophic factors that living muscle and bone normally provide, deprive the brain of signals it needs to remain healthy, thereby accelerating, rather than preventing, neural aging? We term this hypothetical condition cyborg dementia. Rather than a purely engineering problem of motor control and sensory feedback, this reframes brain-machine interface design as fundamentally about preserving the endocrine dialogue between brain and musculoskeletal system, extending the goals of neuroprosthetics beyond restoring action to protecting the neuroendocrine mechanisms that biological embodiment was silently providing all along.

The paperJournal siteMechanisms

AgingResearch.News